tiprankstipranks
Trending News
More News >
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market

Fusen Pharmaceutical Co., Ltd. (1652) Financial Statements

Compare
0 Followers

Fusen Pharmaceutical Co., Ltd. Financial Overview

Fusen Pharmaceutical Co., Ltd.'s market cap is currently HK$595.53M. The company's EPS TTM is HK$-0.034; its P/E ratio is -3.08; Fusen Pharmaceutical Co., Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M¥ 486.85M
Gross Profit¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M¥ 266.07M
Operating Income¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M¥ 103.22M
EBITDA¥ -39.07M¥ 18.93M¥ 49.90M¥ 55.82M¥ 110.30M
Net Income¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M¥ 70.13M
Balance Sheet
Cash & Short-Term Investments¥ 21.06M¥ 34.85M¥ 128.11M¥ 81.70M¥ 312.53M
Total Assets¥ 1.24B¥ 1.34B¥ 1.35B¥ 1.24B¥ 1.24B
Total Debt¥ 383.69M¥ 344.12M¥ 228.38M¥ 240.69M¥ 198.50M
Net Debt¥ 362.64M¥ 309.27M¥ 100.28M¥ 159.63M¥ -98.54M
Total Liabilities¥ 869.80M¥ 781.52M¥ 737.38M¥ 582.39M¥ 583.10M
Stockholders' Equity¥ 369.67M¥ 563.52M¥ 614.17M¥ 658.17M¥ 659.44M
Cash Flow
Free Cash Flow¥ 57.43M¥ -161.84M¥ 86.63M¥ -62.37M¥ 94.56M
Operating Cash Flow¥ 133.73M¥ -73.33M¥ 110.49M¥ 47.77M¥ 153.21M
Investing Cash Flow¥ -163.42M¥ -108.32M¥ -13.13M¥ -282.98M¥ -68.20M
Financing Cash Flow¥ 15.99M¥ 88.50M¥ -51.77M¥ 20.53M¥ -116.33M
Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History

Fusen Pharmaceutical Co., Ltd. Debt to Assets

Fusen Pharmaceutical Co., Ltd. Cash Flow

Fusen Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS